Millions of Doses of Potential COVID Vaccine Ordered Through CT Company
The U.S. Government has placed a mega-order for an experimental COVID-19 vaccine with a CT company.
Pfizer, based in Groton, CT, along with its partner BioNTech SE, has gotten the call from the United States Government to produce 100 million doses of their experimental COVID-19 vaccine that will be given to Americans free of charge. The Government will pay Pfizer nearly $2 billion, according to the Wall Street Journal.
The experimental vaccine has already been given to healthy adult volunteers and has produced higher levels of antibodies after four weeks, compared with the antibodies in recovered COVID-19 patients. No severe side effects have been found.
Currently, 17 vaccines have been approved for human testing, and another 130 are still in the developmental stages. After an extensive in-depth examination, it was determined the optimal dose for the testing subjects was between 10 and 30 micrograms.
Pfizer has plans to produce 100 million doses by the end of 2020, and 1.2 billion doses by the end of 2021. Other Pfizer brands include Advil, Bextra, Celebrex, Diflucan, Lyrica, Robitussin, and Viagra.